Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P-2Y1 purinoceptor

被引:26
|
作者
King, BF [1 ]
Dacquet, C [1 ]
Ziganshin, AU [1 ]
Weetman, DF [1 ]
Burnstock, G [1 ]
Vanhoutte, PM [1 ]
Spedding, M [1 ]
机构
[1] INST RECH SERVIER, F-72890 CROISSY SUR SEINE, FRANCE
基金
英国惠康基金;
关键词
2,2'-pyridylisatogen; P-2; purinoceptor; ATP; adenosine; purinergic transmission; recombinant P-2Y purinoceptor; metabotropic purinoceptor; Xenopus oocyte;
D O I
10.1111/j.1476-5381.1996.tb16704.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 2,2'-Pyridylisatogen tosylate (PIT) has been reported to be an irreversible antagonist of responses to adenosine 5'-triphosphate (ATP) at metabotropic purinoceptors (of the P-2Y family) in some smooth muscles. When a recombinant P-2Y1 purinoceptor (derived from chick brain) is expressed in Xenopus oocytes, ATP and 2-methylthioATP (2-MeSATP) evoke calcium-activated chloride currents (I-Cl,I-Ca) in a concentration-dependent manner. The effects of PIT on these agonist responses were examined at this cloned P-2Y purinoceptor. 2 PIT (0.1-100 mu M) failed to stimulate P-2Y1 purinoceptors directly but, over a narrow concentration range (0.1-3 mu M), caused a time-dependent potentiation (2-5 fold) of responses to ATP. The potentiation of ATP-responses by PIT was not caused by inhibition of oocyte ecto-ATPase. At high concentrations (3-100 mu M), PIT irreversibly inhibited responses to ATP with a IC50 value of 13 +/- 9 mu M (pK(B) = 4.88 +/- 0.22; n = 3). PIT failed to potentiate inward currents evoked by 2-MeSATP and only inhibited the responses to this agonist in an irreversible manner. 3 Known P-2 purinoceptor antagonists were tested for their ability to potentiate ATP-responses at the chick P-2Y1 purinoceptor. Suramin (IC50 = 230 +/- 80 nM; n = 5) and Reactive blue-2 (IC50 = 580 +/- 130 nM; n = 6) reversibly inhibited but did not potentiate ATP-responses. Coomassie brilliant blue-G (0.1- 3 mu M) potentiated ATP-responses in three experiments, while higher concentrations (3-100 mu M) irreversibly inhibited ATP-responses. The results indicated that potentiation and receptor antagonism were dissociable and not a feature common to all known P-2 purinoceptor antagonists. 4 In radioligand binding assays, PIT showed a low affinity (pK(i) < 5) for a range of membrane receptors, including: alpha(1), alpha(2)-adrenoceptors, 5-HT1A, 5-HT1B, 5-HT2, 5-HT3, D-1, D-2, muscarinic, central benzodiazepine, H-1, mu-opioid, dihydropyridine and batrachotoxin receptors. PIT showed some affinity (PKi = 5.3) for an adenosine (A(1)) receptor. 5 In guinea-pig isolated taenia caeci, PIT (12.5-50 mu M) irreversibly antagonized relaxations to ATP (3-1000 CIM); PIT also directly relaxed the smooth muscle and histamine was used to restore tone. Relaxations to nicotine (10-100 mu M), evoked by stimulating intrinsic NANC nerves of taenia caeci preparations in the presence of hyoscine (0.3 mu M) and guanethidine (17 mu M), were not affected by PIT (50 mu M, for 25-60 min). 6 These experiments indicate that PIT causes an irreversible antagonism of ATP receptors but, for recombinant chick P-2Y1 purinoceptors, this effect is preceded by potentiation of ATP agonism. The initial potentiation by PIT (and by Coomassie brilliant blue-G) of ATP-responses raises the possibility of designing a new class of modulatory drugs to enhance purinergic transmission at metabotropic purinoceptors.
引用
收藏
页码:1111 / 1118
页数:8
相关论文
共 50 条
  • [1] Potentiation of ATP-responses at a recombinant P-2X2 receptor by neurotransmitters and related substances
    Wildman, SS
    King, BF
    Burnstock, G
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (02) : 221 - 224
  • [2] Potentiation of ATP-responses at a recombinant P2X(2) receptor by neurotransmitters and related substances
    Wildman, SS
    King, BF
    Burnstock, G
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P130 - P130
  • [3] 2,2′-pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding
    Gao, ZG
    Mamedova, L
    Tchilibon, S
    Gross, AS
    Jacobson, KA
    [J]. BIOCHEMICAL PHARMACOLOGY, 2004, 68 (02) : 231 - 237
  • [4] Prominent sympathetic purinergic vasoconstriction in the rabbit splenic artery: Potentiation by 2,2'-pyridylisatogen tosylate
    Ren, LM
    Burnstock, G
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (03) : 530 - 536
  • [5] Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2′-pyridylisatogen tosylate and related compounds
    Menton, K
    Spedding, M
    Gressens, P
    Villa, P
    Williamson, T
    Markham, A
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 444 (1-2) : 53 - 60
  • [6] TRANSIENT EXPRESSION OF THE RECOMBINANT CHICK BRAIN P-2Y1 PURINOCEPTOR AND LOCALIZATION OF THE CORRESPONDING MESSENGER-RNA
    WEBB, TE
    SIMON, J
    BATESON, AN
    BARNARD, EA
    [J]. CELLULAR AND MOLECULAR BIOLOGY, 1994, 40 (03) : 437 - 442
  • [7] INFLUENCE OF 2-2'-PYRIDYLISATOGEN TOSYLATE ON RESPONSES PRODUCED BY ATP AND BY NEURAL STIMULATION ON RAT GASTRIC CORPUS
    HUNT, WB
    PARSONS, DG
    WAHID, A
    WILKINSON, J
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1978, 63 (02) : P378 - P379
  • [8] Characterisation of a recombinant P-2Y purinoceptor
    Simon, J
    Webb, TE
    King, BF
    Burnstock, G
    Barnard, EA
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 291 (03): : 281 - 289
  • [9] Zn2+ modulation of ATP-responses at recombinant P2X2 receptors and its dependence on extracellular pH
    Wildman, SS
    King, BF
    Burnstock, G
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (06) : 1214 - 1220
  • [10] 2-2' PYRIDYLISATOGEN TOSYLATE - ANTAGONIST OF INHIBITORY EFFECTS OF ATP ON SMOOTH-MUSCLE
    HOOPER, M
    SPEDDING, M
    SWEETMAN, AJ
    WEETMAN, DF
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1974, 50 (03) : P458 - P459